Dosering ved sengetid synes at forbedre tolerabiliteten af disse symptomer og kan anbefales i de første uger af behandlingen samt hos patienter, der fortsat oplever disse symptomer (se pkt. ###>Dosing at bedtime seems to improve the tolerability of these symptoms and can be recommended during the first weeks of therapy and in patients who continue to experience